MarketCapExport financials
Harrow Health (HROW)
The export includes the complete available history of financial statements and ratios. Numbers are provided in full, without million or billion abbreviations, in their original reporting units.
CSV downloads as a ZIP archive with one file for each report and frequency.
Facebook
X
Telegram
Harrow Health Income Statement 2025-1998 | HROW
Brief overview of profit and loss at Harrow Health
The figures are compared over a five-year interval. Revenue at Harrow Health moved from $48.9 million in 2020 to $272 million in 2025. Overall revenue changed by +457.2%, equal to an annualized rate of about 41%. The company expanded its revenue base at a high speed.
Gross profit changed from $34.4 million to $204 million (+494%). Direct costs grew more slowly than revenue and improved the economics of sales. Gross profit as a share of revenue changed from 70.4% to 75.1%. The margin shift points to a more favorable sales-and-cost structure.
EBITDA changed from 3.5 million dollars to 31.8 million dollars (+811.8%). EBITDA expanded faster than the top line. At the operating-margin level, the figure shifted from 7.1% to 11.7%. Higher profitability strengthens the quality of operating growth.
The net financial result changed from −3.4 million dollars to −5.1 million dollars. Profitability deteriorated further over the five years.
Market value was $233 million at the start and $1.9 billion at the end. The higher valuation contrasts with weaker financial performance.
Financial takeaway
The financial profile remains mixed, with strengths and risks moving in different directions. The constructive conclusion rests on better sales economics, revenue expansion and an improving EBITDA margin. The overall view is constrained by a weaker final result. Further direction will depend on top-line growth, operating profitability, and net income.
Annual Income Statement Harrow Health
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
1.93 B | 1.88 B | 347 M | 479 M | 206 M | 233 M | 163 M | 132 M | 38.5 M | 30.1 M | 57.1 M | 67.3 M | 71 M | 37.1 M | 1.43 M | 637 M | - | - | - | - | - | - | - | - | - | - | - | - |
Shares |
36.8 M | 35.7 M | 32.6 M | 27.5 M | 26.8 M | 25.9 M | 25.3 M | 21.9 M | 20 M | 12.7 M | 9.58 M | 9.13 M | 8.66 M | 4.49 M | 398 K | 15.9 M | - | - | 46.2 K | - | - | - | - | - | - | - | - | - |
Historical Prices |
52.6 | 52.6 | 10.7 | 17.5 | 7.71 | 7.67 | 5.52 | 6.94 | 1.82 | 2.44 | 4.08 | 7.5 | 8.65 | 4.99 | 2.8 | 40 | 32 | 64 | - | - | - | - | - | - | - | - | - | - |
Net Income |
-5.14 M | -17.5 M | -24.4 M | -14.1 M | -18 M | -3.36 M | 168 K | 14.6 M | -12 M | -19.1 M | -15.9 M | -10.1 M | -7.64 M | -5.38 M | -954 K | -2.53 M | -4.55 M | -3.3 M | -4.28 M | -584 K | -540 K | -508 K | -207 K | -228 K | -208 K | -213 K | -204 K | -100 K |
Revenue |
272 M | 200 M | 130 M | 88.6 M | 72.5 M | 48.9 M | 51.2 M | 41.4 M | 26.8 M | 19.9 M | 9.72 M | 1.66 M | 10 K | 100 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
67.9 M | 49.2 M | 39.6 M | 25.4 M | 18.2 M | 14.5 M | 16.7 M | 16.5 M | 13.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
204 M | 150 M | 90.6 M | 63.2 M | 54.3 M | 34.4 M | 34.4 M | 24.9 M | 13.3 M | 10.1 M | 4.51 M | 567 K | 10 K | 100 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
30.5 M | 8.82 M | 431 K | 1.92 M | 1.61 M | 385 K | -4.8 M | -5.22 M | -12.2 M | -15.9 M | -14.8 M | -10.1 M | -7.69 M | -4.18 M | -939 K | -2.5 M | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
47 K | -185 K | 21.3 M | 7.24 M | 5.44 M | -73 K | 630 K | 103 K | -884 K | 1.54 M | -1.11 M | 3.8 K | - | 24.7 K | 75 K | 55.5 K | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
31.8 M | 10.1 M | 1.49 M | 3.17 M | 3.19 M | 3.49 M | 1.9 M | -3.37 M | -10.4 M | -14.2 M | -14.2 M | -10.1 M | -7.68 M | -4.18 M | -939 K | -2.5 M | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
174 M | 142 M | 90.1 M | 61.3 M | 52.6 M | 33.7 M | 35.2 M | 30.1 M | 25.4 M | 25.7 M | 19.3 M | 10.7 M | 7.7 M | 4.28 M | 939 K | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
153 M | 129 M | 83.1 M | 58.2 M | 41.3 M | 31.2 K | - | - | 18 M | 17.6 M | 12.5 M | 8.09 M | - | - | - | 2.31 M | - | - | - | - | - | - | - | - | - | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Quarterly Income Statement Harrow Health
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
36.8 M | 37.2 M | - | 37.1 M | 36.8 M | 35.8 M | 35.6 M | 35.7 M | 35.6 M | 35.5 M | 35.2 M | 34.3 M | 30.5 M | 30.3 M | 29.9 M | 27.3 M | 27.3 M | 27.2 M | 26.9 M | 27.1 M | 26.7 M | 26 M | 25.7 M | 25.9 M | 25.9 M | 25.9 M | 25.5 M | 25.6 M | 25.2 M | 24.8 M | 24.3 M | 21.7 M | 21.2 M | 20.9 M | 20.6 M | 20.3 M | 20.2 M | 18.9 M | 18.6 M | 13.5 M | 13.3 M | 10.4 M | 9.76 M | 9.6 M | 9.5 M | 9.34 M | 9.26 M | 9.15 M | 9.11 M | 9.01 M | 8.97 M | 8.96 M | 8.89 M | 7.79 M | 6.77 M | 6.22 M | 3.87 M | 1.06 M | 398 K | 1.99 M | 1.99 M | 1.99 M |
Net Income |
5 M | -27.6 M | - | 1.02 M | 5 M | -17.8 M | - | -4.22 M | -6.47 M | -13.6 M | - | -4.39 M | -4.23 M | -6.64 M | - | -6.46 M | -6.24 M | -2.44 M | - | -8.33 M | -2.48 M | 217 K | - | 8.64 M | -237 K | -12.9 M | - | -11.5 M | -2.38 M | 11.4 M | - | -2.51 M | 2.52 M | -3.51 M | - | -5.69 M | 1.48 M | -5.01 M | - | -3.85 M | -4.64 M | -4.5 M | - | -3.95 M | -3.73 M | -3.09 M | - | -2.45 M | -2.6 M | -2.32 M | - | -2.08 M | -2.22 M | -1.47 M | - | -1.25 M | -1.31 M | -1.38 M | - | -85.4 K | -164 K | -432 K |
Revenue |
63.7 M | 44.2 M | - | 71.6 M | 63.7 M | 47.8 M | - | 49.3 M | 48.9 M | 34.6 M | - | 34.3 M | 33.5 M | 26.1 M | - | 22.8 M | 23.3 M | 22.1 M | - | 18.7 M | 18.1 M | 15.4 M | - | 14.4 M | 8.06 M | 11.8 M | - | 12.8 M | 13.5 M | 12.3 M | - | 10.7 M | 10.4 M | 8.86 M | - | 6.48 M | 6.86 M | 6.1 M | - | 4.86 M | 4.91 M | 4.38 M | - | 2.68 M | 1.97 M | 1.56 M | - | 441 K | 667 K | 2 K | - | 2.5 K | 2.5 K | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
16.2 M | 17.2 M | - | 17.7 M | 16.2 M | 15.5 M | - | 12 M | 12.5 M | 10.6 M | - | 10.1 M | 10 M | 8.27 M | - | 6.72 M | 6.53 M | 5.96 M | - | 4.95 M | 4.42 M | 3.77 M | - | 3.7 M | 3.2 M | 3.63 M | - | 4.06 M | 5.22 M | 3.9 M | - | 4.19 M | 4.16 M | 4.07 M | - | 3.4 M | 3.29 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
47.5 M | 27 M | - | 53.9 M | 47.5 M | 32.3 M | - | 37.2 M | 36.4 M | 24 M | - | 24.2 M | 23.5 M | 17.8 M | - | 16.1 M | 16.8 M | 16.2 M | - | 13.8 M | 13.7 M | 11.7 M | - | 10.7 M | 4.86 M | 8.19 M | - | 8.69 M | 8.29 M | 8.39 M | - | 6.55 M | 6.23 M | 4.79 M | - | 3.08 M | 3.57 M | 2.74 M | - | 2.52 M | 2.74 M | 2.13 M | - | 1.48 M | 917 K | 556 K | - | 202 K | 191 K | 2 K | - | 2.5 K | 2.5 K | - | - | - | - | - | - | - | - | - |
Operating Income |
11.4 M | -22.1 M | - | 14.7 M | 11.4 M | -11.2 M | - | 1.32 M | 1.53 M | -6.93 M | - | 1.74 M | 2.35 M | 1.21 M | - | -94 K | 1.69 M | 2.1 M | - | -3.72 M | 4.17 M | 2.92 M | - | 1.6 M | -3.21 M | -628 K | - | -4.4 M | -767 K | -556 K | - | -649 K | -624 K | -1.78 M | - | -2.76 M | -3.02 M | -4.23 M | - | -4.61 M | -4.01 M | -3.75 M | - | -3.53 M | -3.48 M | -3.12 M | - | -2.46 M | -2.6 M | -2.34 M | - | -2.09 M | -2.23 M | -1.47 M | - | -1.25 M | -1.12 M | -352 K | - | -66.5 K | -146 K | -414 K |
Interest Expense |
-6 K | - | - | 61 K | -6 K | - | - | 4 K | 46 K | 5.42 M | - | -195 K | -178 K | 4.75 M | - | 1.8 M | 1.79 M | 1.79 M | - | 1.68 M | 1.31 M | 513 K | - | 498 K | 19 K | -560 K | - | 630 K | 630 K | 630 K | - | -255 K | -255 K | -663 K | - | -793 K | -767 K | -788 K | - | 1.49 M | -631 K | -629 K | - | -423 K | -249 K | -7 K | - | 993 | 7 K | 10 K | - | - | - | - | - | - | 3.58 K | 21.1 K | - | 18.9 K | 18.7 K | 18.5 K |
EBITDA |
15.6 M | -21.6 M | - | 15.1 M | 11.8 M | -10.9 M | - | 1.67 M | 1.83 M | -6.63 M | - | 2.03 M | 2.58 M | 1.44 M | - | 77 K | 2.07 M | 2.52 M | - | -2.44 M | 5.04 M | 3.38 M | - | 2.06 M | -2.74 M | -180 K | - | -4 M | -276 K | -166 K | - | 574 K | 176 K | -1.38 M | - | -1.72 M | -2.36 M | -3.89 M | - | -3.91 M | -3.66 M | -3.67 M | - | -3.34 M | -3.38 M | -3.07 M | - | -2.44 M | -2.59 M | -2.33 M | - | -2.09 M | -2.23 M | -1.47 M | - | -1.25 M | -1.12 M | -352 K | - | -66.5 K | -146 K | -414 K |
Operating Expenses |
36.1 M | 49.1 M | - | 39.2 M | 36.1 M | 43.5 M | - | 35.9 M | 34.9 M | 31 M | - | 22.5 M | 21.1 M | 16.6 M | - | 16.2 M | 15.1 M | 14.1 M | - | 17.5 M | 9.55 M | 8.76 M | - | 9.11 M | 8.07 M | 8.82 M | - | 13.1 M | 9.06 M | 8.95 M | - | 7.2 M | 6.85 M | 6.58 M | - | 5.84 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
33.2 M | 43.2 M | - | 35.9 M | 33.2 M | 40.5 M | - | 33.6 M | 31.8 M | 28.8 M | - | 21 M | 20 M | 15.9 M | - | 15.4 M | 14.2 M | 13.4 M | - | 11.4 M | 9.12 M | 8.16 M | - | 8.44 M | 6.95 M | 8.42 M | - | 8.61 M | 8.25 M | 8.54 M | - | 6.96 M | 6.78 M | 6.49 M | - | 4.49 M | 4.49 M | 4.37 M | - | 5.02 M | 4.4 M | 3.94 M | - | 3.1 M | 2.74 M | 2.48 M | - | 1.95 M | 2.29 M | 1.9 M | - | 1.62 M | 1.56 M | 1.02 M | - | 946 K | 985 K | 309 K | - | 66.5 K | 121 K | 327 K |
Quarterly performance
Select metrics to display
All numbers in USD currency
The income statement is one of the three key financial reports of a company Harrow Health (alongside the balance sheet and the cash flow statement). It shows how the company makes money and what its expenses are:
- How much revenue the company earned
- How much it spent on production, personnel, marketing, taxes, etc.
- What profit remained in the end
Analyzing the income statement helps an investor understand whether the business generates stable and growing profits, how effectively the company controls its expenses, and whether it is capable of generating income in the future. Additionally, this analysis shows how the company copes with crises and economic cycles, and allows assessing the potential for stock price growth and dividend payments.
Features- The income statement may include both recurring and one-time items (for example, profit from the sale of assets). It is necessary to separate core metrics from one-off events for accurate analysis.
- Companies often publish interim reports (e.g., quarterly), which allows for more timely tracking of trends.
- A combined analysis of the income statement with the balance sheet and cash flow statement provides a comprehensive view of the company’s financial health.
USA
France
Irlanda
Canada
China
Schweden
